Inovio Pharmaceuticals Inc (NASDAQ:INO) has a beta value of 0.87 and has seen 4.58 million shares traded in the last trading session. The company, currently valued at $82.30M, closed the last trade at $2.28 per share which meant it gained $0.35 on the day or 18.13% during that session. The INO stock price is -546.93% off its 52-week high price of $14.75 and 23.68% above the 52-week low of $1.74. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.04 million shares traded. The 3-month trading volume is 750.61K shares.
The consensus among analysts is that Inovio Pharmaceuticals Inc (INO) is Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 3 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Inovio Pharmaceuticals Inc (NASDAQ:INO) trade information
Sporting 18.13% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the INO stock price touched $2.28 or saw a rise of 4.6%. Year-to-date, Inovio Pharmaceuticals Inc shares have moved 24.59%, while the 5-day performance has seen it change 28.09%. Over the past 30 days, the shares of Inovio Pharmaceuticals Inc (NASDAQ:INO) have changed -43.28%. Short interest in the company has seen 3.5 million shares shorted with days to cover at 11.22.
Wall Street analysts have a consensus price target for the stock at $8, which means that the shares’ value could jump 71.5% from current levels. The projected low price target is $8.0 while the price target rests at a high of $8.0. In that case, then, we find that the current price level is -250.88% off the targeted high while a plunge would see the stock gain -250.88% from current levels.
Inovio Pharmaceuticals Inc (INO) estimates and forecasts
Figures show that Inovio Pharmaceuticals Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -75.05% over the past 6 months, with this year growth rate of 26.77%, compared to 16.90% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 13.49% over the past 5 years. Earnings growth for 2025 is a modest 28.41% while over the next 5 years, the company’s earnings are expected to increase by 41.50%.
INO Dividends
Inovio Pharmaceuticals Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Inovio Pharmaceuticals Inc (NASDAQ:INO)’s Major holders
Insiders own 0.85% of the company shares, while shares held by institutions stand at 33.51% with a share float percentage of 33.80%. Investors are also buoyed by the number of investors in a company, with Inovio Pharmaceuticals Inc having a total of 129.0 institutions that hold shares in the company.
